Highlights Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Market Closed - Toronto S.E. Other stock markets 09:30:00 2024-05-30 EDT			5-day change	1st Jan Change
0.025 ^CAD	-.--%		+25.00%	-.--%

04-30	Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-27	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Waverley Pharma Provides Business Update	23-03-20	MT
Waverley Pharma Inc. Provides Update on its PARP-1 Inhibitor Program	23-01-11	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-24	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-26	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-26	CI
Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-25	CI
Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-26	CI
Waverley Pharma : Awarded 2-Year Tender For Oncology Drug With NHS Scotland	21-01-18	MT
Waverley Pharma Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-26	CI
Waverley Pharma : Says U.S. Gives Tentative Approval For Pemetrexed Abbreviated New Drug Application	20-11-12	MT
Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States	20-11-12	CI
Waverley Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Highlights

Filters